Alpha 2.0
Login Register
» Articles » PMID: 3744386

Mechanisms of Tumor Growth Inhibition

Overview
Journal Hybridoma
Publisher Mary Ann Liebert
Specialty Cell Biology
Date 1986 Jul 1
PMID 3744386
Citations 8
Authors
Z Steplewski
D Herlyn
M Lubeck
Y Kimoto
M Herlyn
H KOPROWSKI
Affiliations
Soon will be listed here.
Citing Articles

Antibodies: At The Nexus of Antigens and Cancer Vaccines.

Steplewski Z, Thurin M, Kieber-Emmons T J Infect Dis. 2015; 212 Suppl 1:S59-66.

PMID: 26116735 PMC: 4490205. DOI: 10.1093/infdis/jiu638.

Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

Zbar A, Lemoine N, Wadhwa M, Thomas H, Snary D, Kmiot W Br J Cancer. 1998; 77(5):683-93.

PMID: 9514045 PMC: 2149974. DOI: 10.1038/bjc.1998.114.

m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer.

Pullyblank A, Guillou P, Monson J Br J Cancer. 1994; 70(4):753-8.

PMID: 7917934 PMC: 2033396. DOI: 10.1038/bjc.1994.390.

Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity.

Pullyblank A, Guillou P, Monson J Br J Cancer. 1995; 72(3):601-6.

PMID: 7669568 PMC: 2033875. DOI: 10.1038/bjc.1995.380.

Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies.

Ragnhammar P, Frodin J, Trotta P, Mellstedt H Cancer Immunol Immunother. 1994; 39(4):254-62.

PMID: 7525059 PMC: 11038671. DOI: 10.1007/BF01525989.